Source: PRZOOM

Press Release: Tergus Pharma : Tergus Lauded by Frost & Sullivan for its Full-spectrum CRO Services for Therapeutics in Dermatology

PRZOOM - Newswire (press release) - Mon, 08 Mar 2021 00:00:00 -0500, Santa Clara CA United States - With scalable, advanced resource and technology capabilities, Tergus presents pharma companies with exceptional CRO services for all their drug discovery and development requirements - TergusPharma.com / Frost.com

Read full article »

Tergus Pharma's Competitors | Tergus Pharma's News | Tergus Pharma's Financials

Followers on Owler

187

Est. Annual Revenue

$5.0-25M

Est. Employees

100-250

CEO

Michael Kane

CEO Approval Rating

82/100

Tergus is a North Carolina-based CDMO that provides services such as formulation development, cGMP testing and process validation for the pharmaceutical sector.